BRPI0608136A2 - base livre de lercanidipina - Google Patents
base livre de lercanidipinaInfo
- Publication number
- BRPI0608136A2 BRPI0608136A2 BRPI0608136-3A BRPI0608136A BRPI0608136A2 BR PI0608136 A2 BRPI0608136 A2 BR PI0608136A2 BR PI0608136 A BRPI0608136 A BR PI0608136A BR PI0608136 A2 BRPI0608136 A2 BR PI0608136A2
- Authority
- BR
- Brazil
- Prior art keywords
- free base
- lercanidipine free
- lercanidipine
- purity
- formulation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Abstract
BASE LIVRE DE LERCANIDIPINA. A invenção fornece base livre de lercanidipina substancialmente pura, que tem uma pureza de pelo menos 95%, preferivelmente pelo menos cerca de 97%, mais preferivelmente pelo menos cerca de 99%, e ainda mais preferivelmente pelo menos cerca de 99,5%. A base livre de lercanidipina da presente invenção é formada como um sólido amorfo que é facilmente manuseado e particularmente bem adequado para a formulação de composições farmacêuticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65674105P | 2005-02-25 | 2005-02-25 | |
PCT/EP2006/001783 WO2006089788A1 (en) | 2005-02-25 | 2006-02-24 | Lercanidipine free base |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0608136A2 true BRPI0608136A2 (pt) | 2009-11-17 |
Family
ID=36587241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0608136-3A BRPI0608136A2 (pt) | 2005-02-25 | 2006-02-24 | base livre de lercanidipina |
Country Status (18)
Country | Link |
---|---|
US (1) | US20060199849A1 (pt) |
EP (1) | EP1853562A1 (pt) |
JP (1) | JP2008531516A (pt) |
KR (1) | KR20070105978A (pt) |
CN (1) | CN101142186A (pt) |
AR (1) | AR053023A1 (pt) |
AU (1) | AU2006218027A1 (pt) |
BR (1) | BRPI0608136A2 (pt) |
CA (1) | CA2597992A1 (pt) |
EA (1) | EA200701686A1 (pt) |
IL (1) | IL184348A0 (pt) |
MX (1) | MX2007010362A (pt) |
NO (1) | NO20074873L (pt) |
PE (1) | PE20061393A1 (pt) |
TW (1) | TW200640860A (pt) |
UY (1) | UY29400A1 (pt) |
WO (1) | WO2006089788A1 (pt) |
ZA (1) | ZA200708126B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100651212B1 (ko) * | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
WO2008040367A1 (en) * | 2006-08-01 | 2008-04-10 | Union Quimico-Farmaceutica S.A. | Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof |
DE102010005124A1 (de) * | 2010-01-19 | 2012-03-01 | Stada Arzneimittel Ag | Feste pharmazeutische Zusammensetzung umfassend Lercanidipin |
CN102531999B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 无定形盐酸乐卡地平及其制备方法 |
CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
IT1275532B (it) * | 1995-07-14 | 1997-08-07 | Recordati Chem Pharm | Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa |
US5696139A (en) * | 1995-05-12 | 1997-12-09 | Recordati S.A., Chemical And Pharmaceutical Company | Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure |
IT1298732B1 (it) * | 1998-03-13 | 2000-02-02 | Recordati Chem Pharm | Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione |
US6852737B2 (en) * | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
US20030069285A1 (en) * | 2001-08-06 | 2003-04-10 | Recordati Ireland Limited | Novel solvate and crystalline forms of lercanidipine hydrochloride |
US20030180355A1 (en) * | 2001-10-16 | 2003-09-25 | Amedeo Leonardi | Combination therapy for hypertension |
JP2006504800A (ja) * | 2002-10-16 | 2006-02-09 | レコーダチ アイルランド リミテッド | リシノプリル/レルカニジピンの組み合わせ治療 |
US20040147566A1 (en) * | 2002-10-16 | 2004-07-29 | Amedeo Leonardi | Lisinopril/lercanidipine combination therapy |
US20040198789A1 (en) * | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
KR20060125824A (ko) * | 2003-12-01 | 2006-12-06 | 라이프사이클 파마 에이/에스 | 레르카니디핀을 포함한 약학적 조성물 |
TW200613275A (en) * | 2004-08-24 | 2006-05-01 | Recordati Ireland Ltd | Lercanidipine salts |
TW200616681A (en) * | 2004-10-05 | 2006-06-01 | Recordati Ireland Ltd | Lercanidipine capsules |
-
2006
- 2006-02-22 AR ARP060100640A patent/AR053023A1/es not_active Application Discontinuation
- 2006-02-24 UY UY29400A patent/UY29400A1/es unknown
- 2006-02-24 AU AU2006218027A patent/AU2006218027A1/en not_active Abandoned
- 2006-02-24 EP EP06723129A patent/EP1853562A1/en not_active Withdrawn
- 2006-02-24 BR BRPI0608136-3A patent/BRPI0608136A2/pt not_active Application Discontinuation
- 2006-02-24 WO PCT/EP2006/001783 patent/WO2006089788A1/en active Application Filing
- 2006-02-24 MX MX2007010362A patent/MX2007010362A/es not_active Application Discontinuation
- 2006-02-24 KR KR1020077017757A patent/KR20070105978A/ko not_active Application Discontinuation
- 2006-02-24 EA EA200701686A patent/EA200701686A1/ru unknown
- 2006-02-24 CA CA002597992A patent/CA2597992A1/en not_active Abandoned
- 2006-02-24 PE PE2006000225A patent/PE20061393A1/es not_active Application Discontinuation
- 2006-02-24 JP JP2007556566A patent/JP2008531516A/ja not_active Withdrawn
- 2006-02-24 TW TW095106335A patent/TW200640860A/zh unknown
- 2006-02-24 CN CNA2006800055031A patent/CN101142186A/zh active Pending
- 2006-02-27 US US11/364,861 patent/US20060199849A1/en not_active Abandoned
-
2007
- 2007-07-02 IL IL184348A patent/IL184348A0/en unknown
- 2007-09-21 ZA ZA200708126A patent/ZA200708126B/xx unknown
- 2007-09-25 NO NO20074873A patent/NO20074873L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20060199849A1 (en) | 2006-09-07 |
AU2006218027A1 (en) | 2006-08-31 |
EA200701686A1 (ru) | 2008-02-28 |
KR20070105978A (ko) | 2007-10-31 |
UY29400A1 (es) | 2006-06-30 |
NO20074873L (no) | 2007-11-22 |
IL184348A0 (en) | 2007-10-31 |
JP2008531516A (ja) | 2008-08-14 |
CN101142186A (zh) | 2008-03-12 |
MX2007010362A (es) | 2007-10-17 |
TW200640860A (en) | 2006-12-01 |
PE20061393A1 (es) | 2007-01-16 |
ZA200708126B (en) | 2008-11-26 |
AR053023A1 (es) | 2007-04-18 |
WO2006089788A1 (en) | 2006-08-31 |
CA2597992A1 (en) | 2006-08-31 |
EP1853562A1 (en) | 2007-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122861T1 (el) | Φαρμακευτικες συνθεσεις της αμορφης μορφης ν-[2,4-δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3-καρβοξαμιδιου | |
BRPI0608138A2 (pt) | cloridrato de lercanidipina amorfa | |
BRPI0515880A (pt) | produção de gás livre por conversão de hidrato de gás | |
GT200600194A (es) | Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada | |
NI200600240A (es) | FORMA CRISTALINA Delta-d CLORHIDRATO DE LA IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN, Y LAS COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
BRPI0609121B8 (pt) | 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2 | |
CU23614B7 (es) | Forma cristalina beta del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que la contienen | |
CU20060037A7 (es) | Forma cristalina gamma del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
ECSP066883A (es) | Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes | |
UY29839A1 (es) | Ácidos fenoxiaceticos sustituidos, composiciones farmacéuticas conteniéndolos, procesos para su preparación y aplicaciones. | |
UY29636A1 (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
ECSP066376A (es) | FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
HN2006018410A (es) | Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion | |
UY30220A1 (es) | Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo | |
PA8846901A1 (es) | Inhibidores de cinasa akt y p70 s6. | |
BRPI0608136A2 (pt) | base livre de lercanidipina | |
SV2009002900A (es) | Diarilurea para el tratamiento de hipertension pulmonar | |
BRPI0620229B8 (pt) | formulações farmaceuticas e processos de produção da ditas formulações | |
BRPI0806713A8 (pt) | Composições de tiacumicinas estáveis | |
BRPI0600167A (pt) | processo para destilação de uma mistura de diisocianato-difenilimetanos isoméricos | |
BRPI1016069A8 (pt) | Misturas de ésteres e composições compreendendo tais misturas de ésteres | |
BRPI0603197A (pt) | composição de toner | |
NI200900207A (es) | Una composición de liberación prolongada que comprende un derivado de somatostatina en micropartículas. | |
BRPI0511135B8 (pt) | formulação de aerossol para a inalação de beta-agonistas | |
BRPI0603785A (pt) | lubrifcante pessoal borrifável |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |